Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
H2AFV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SKAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BICD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TYMS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIPK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERV3-2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
FAM133DP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VPS50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYX1C1-CCPG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DTX3L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYB5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2V2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNLT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRIT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EZH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGF2BP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KMT2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on